Application of a WeChat Mini Program to provide pharmaceutical care for cancer pain patients: A randomized controlled trial
Open Access
- 1 January 2024
- journal article
- research article
- Published by SAGE Publications in Digital Health
- Vol. 10
Abstract
Objective: This study aimed to develop an individual WeChat Mini Program to provide pharmaceutical care to better manage cancer pain patients and to evaluate its feasibility and the differences in analgesic efficacy, medication adherence and safety versus conventional pharmacy interventions. Methods: In this parallel randomized clinical trial, 42 cancer pain patients were equally allocated into the experimental group and the control group. The experimental group received individualized pharmaceutical care based on the “Yao Nin You Wo” WeChat Mini Program, while the control group received conventional care during the 4-week period. Main outcomes contained pain scores, medication adherence, incidences and relief rates of breakthrough pain, and incidences of adverse events. Relief rates of pain were also calculated according to pain scores. Results: At the beginning of intervention, none of the pain scores and medication adherence showed relevant differences between the two groups (all P > .05). After intervention, the experimental group had significantly lower pain scores compared to the control group ( P = .003). Breakthrough pain of both groups was alleviate; not only the incidence of breakthrough pain considerably was lower at 4 weeks than at baseline, but the relief rate of breakthrough in the experimental group was higher than that in the control group. Compared with the control group, the medication adherence rate of the experimental group was significantly improved ( P = .02). Types of adverse events that happened in experimental and groups were similar, but the total incidence of adverse events in the experimental group was lower than that in the control group. Conclusions: WeChat Mini Program is a useful and facilitative tool with the potential to improve cancer pain self-management ability in discharged patients. In addition, pharmacists could play a key role through the Mini Program to connect with patients successfully by providing personalized pharmaceutical services.Keywords
Funding Information
- Beijing Health Alliance Charitable Foundation ((Grant No.WS058C; Grant No. yxky-TQ20210))
- Fujian Cancer Hospital Cultivation project (Grant No.2023YN11)
This publication has 27 references indexed in Scilit:
- Practice review: Evidence-based and effective management of pain in patients with advanced cancerPalliative Medicine, 2020
- Relationships between patient-related attitudinal barriers, analgesic adherence and pain relief in Chinese cancer inpatientsSupportive Care in Cancer, 2019
- The Relation Between Patients’ Beliefs About Pain Medication, Medication Adherence, and Treatment Outcome in Chronic Pain PatientsThe Clinical Journal of Pain, 2019
- Optimal pain management for patients with cancer in the modern eraCA: A Cancer Journal for Clinicians, 2018
- Intravenous Oxycodone versus Intravenous Morphine in Cancer Pain: A Randomized, Open-Label, Parallel-Group, Active-Control StudyPain Research and Management, 2017
- Self-management education interventions for patients with cancer: a systematic reviewSupportive Care in Cancer, 2017
- Breakthrough cancer pain: twenty-five years of studyPain, 2016
- Pharmacists' roles in oncology pharmacy services: Results of a global surveyJournal of Oncology Pharmacy Practice, 2016
- Does Adherence to National Comprehensive Cancer Network Guidelines Improve Pain-Related Outcomes? An Evaluation of Inpatient Cancer Pain Management at an Academic Medical CenterJournal of Pain and Symptom Management, 2014
- Considerations in determining sample size for pilot studiesResearch in Nursing & Health, 2008